Meet the DCCPS New and Early Stage R01 Investigators

  • Kimberly Canter, Ph.D.
    Alfred I. duPont Hospital for Children
    Pediatric Psychologist and Psychosocial Researcher

    My interest in serving this population began in college, when a lightbulb went off during an introductory psychology class. I had planned to pursue a career in medicine but was much more interested in the opportunity to help patients and families cope and manage stressors. My personal and professional experiences with cancer have fueled my passion to provide high-quality, accessible psychosocial care to families as they navigate what is likely one of the worst times of their lives.
  • Norah L. Henry, M.D., Ph.D.
    University of Michigan - Ann Arbor
    Breast Oncologist and Clinical and Translational Researcher

    Every week in clinic I see the struggles that patients with breast cancer face trying to tolerate their life-saving cancer medications. This has inspired me to understand what underlies the difficulties with medication compliance, and to explore interventions to reduce these challenges. I strive to help people keep taking their medications while maintaining their quality of life.
  • Matthew C. Hocking, Ph.D.
    Children's Hospital of Philadelphia
    Pediatric Psychologist and Behavioral Scientist

    As a graduate student, I worked in a multidisciplinary clinic where I conducted psychological consultations for survivors of childhood cancer. The experience of meeting these youth who had been cured of their cancer but were experiencing significant health problems and developmental issues had a substantial impact on me. I became particularly fascinated by the effects of cancer treatments on the developing brain and the different problems that occur as a result.
  • Kelly Kenzik, Ph.D.
    University of Alabama at Birmingham
    Epidemiologist and Health Services Researcher

    I have been driven by the notion that we can create the best medical centers and the most advanced therapies, yet these are only accessible and usable by a fragment of the population in need. This has continued to motivate me to pursue a line of research that helps to bridge this gap.
  • Folasade P. May, M.D., Ph.D., M.Phil.
    University of California - Los Angeles
    Physician Scientist

    My career and research are driven by my basic belief that all individuals, regardless of background, should have access to high-quality healthcare and health information that empowers them to make their personal health decisions.
  • Shivan J. Mehta, M.D., M.B.A., M.S.H.P.
    University of Pennsylvania
    Gastroenterologist and Health Care Delivery Scientist

    An important moment for my research interests was realizing the importance of co-creating health care delivery interventions with clinical and operational leaders while employing rigorous research methods such as prospective randomization in pragmatic trials. This process has identified delivery programs with high potential to improve outcomes while also creating generalizable knowledge that can advance the science of population-based cancer screening.
  • Aaron P. Mitchell, M.D., M.P.H.
    Memorial Sloan Kettering Cancer Center
    Medical Oncologist and Health Services Researcher

    I first became interested in understanding the causes – and the resultant harms – of unwarranted variation in medical care during medical school at NYU. NYU students divide their time between the private Tisch hospital and Bellevue, a New York City municipal hospital. I was struck by how, just a few city blocks apart, different patients were simultaneously suffering from overtreatment and undertreatment.
  • Erin Rogers, Dr.P.H.
    New York University School of Medicine
    Public Health Researcher

    While working as a smoking cessation research coordinator in safety-net clinics, I realized that traditional approaches to treating tobacco use were ignoring the structural and social determinants of health that were making it difficult for patients to engage in treatment and quit smoking.
  • Kirk J. Wangensteen, M.D., Ph.D.
    University of Pennsylvania

    I am driven to link genes to associated functions in liver diseases and I hope to make discoveries that make positive impacts on patients.
  • Chong Wu
    MD Anderson Cancer Center

    As a biostatistician, I was fascinated by the opportunity to collaborate with researchers with diverse backgrounds, ranging from pure statisticians to epidemiologists to clinicians. Motivated by the challenging problems imposed by complex genetic and genomics datasets, my research aims to develop novel statistical methods and software that can help us better understand the etiology and improve risk stratification for cancer.
  • Lang Wu, Ph.D.
    University of Hawaii at Manoa
    Genetic and Molecular Epidemiologist

    During the first year of my PhD study, I had hands-on experience analyzing large-scale Genome-Wide Association Study data. I quickly decided that I would pursue this area of genetic epidemiology as the direction of my scientific career.